Literature DB >> 16014356

PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle.

Lily Q Dong1, Feng Liu.   

Abstract

Activation of members of the protein kinase AGC (cAMP dependent, cGMP dependent, and protein kinase C) family is regulated primarily by phosphorylation at two sites: a conserved threonine residue in the activation loop and a serine/threonine residue in a hydrophobic motif (HM) near the COOH terminus. Although phosphorylation of these kinases in the activation loop has been found to be mediated by phosphoinositide-dependent protein kinase-1 (PDK1), the kinase(s) that catalyzes AGC kinase phosphorylation in the HM remains uncharacterized. So far, at least 10 kinases have been suggested to function as an HM kinase or the so-called "PDK2," including mitogen-activated protein (MAP) kinase-activated protein kinase-2 (MK2), integrin-linked kinase (ILK), p38 MAP kinase, protein kinase Calpha (PKCalpha), PKCbeta, the NIMA-related kinase-6 (NEK6), the mammalian target of rapamycin (mTOR), the double-stranded DNA-dependent protein kinase (DNK-PK), and the ataxia telangiectasia mutated (ATM) gene product. However, whether any or all of these kinases act as a physiological HM kinase remains to be established. Nonetheless, available data suggest that multiple systems may be used in cells to regulate the activation of the AGC family kinases. It is possible that, unlike activation loop phosphorylation, phosphorylation of the HM site in the different AGC family kinases is mediated by distinct kinases. In addition, phosphorylation of the AGC family kinase at the HM site could be cell type, signaling pathway, and substrate specific. Identification and characterization of the bonafide HM kinase(s) will be essential to verify these hypotheses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014356     DOI: 10.1152/ajpendo.00011.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  58 in total

Review 1.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

2.  Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.

Authors:  Delphine Boulbes; Chien-Hung Chen; Tattym Shaikenov; Nitin K Agarwal; Timothy R Peterson; Terri A Addona; Hasmik Keshishian; Steven A Carr; Mark A Magnuson; David M Sabatini; Dos D Sarbassov
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

Review 3.  Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.

Authors:  Nathan T Ihle; Garth Powis
Journal:  Mol Aspects Med       Date:  2010-02-20

4.  CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4.

Authors:  Thomas Slagsvold; Adriano Marchese; Andreas Brech; Harald Stenmark
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

Review 5.  Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

Authors:  Sanford R Sampson; Denise R Cooper
Journal:  Mol Genet Metab       Date:  2006-06-23       Impact factor: 4.797

6.  A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation.

Authors:  Kyoungja Hong; Liguang Lou; Sandhya Gupta; Fernando Ribeiro-Neto; Daniel L Altschuler
Journal:  J Biol Chem       Date:  2008-06-12       Impact factor: 5.157

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

8.  PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1.

Authors:  Shuhua Xia; Zhihong Chen; Lora W Forman; Douglas V Faller
Journal:  Cell Signal       Date:  2008-12-10       Impact factor: 4.315

9.  Freud-1/Aki1, a novel PDK1-interacting protein, functions as a scaffold to activate the PDK1/Akt pathway in epidermal growth factor signaling.

Authors:  Akito Nakamura; Mikihiko Naito; Takashi Tsuruo; Naoya Fujita
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

Review 10.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.